Upvote
Downvote
Chief Scientific Officer
Share Job
- Suggest Revision
$250
- AcuraStem is a patient-based biotechnology company pioneering treatments for neurodegenerative diseases, including ALS and FTD. AcuraStem’s best-in-class disease modeling platform, iNeuroRx, enables the discovery of innovative, effective, and broadly acting treatments.
- AcuraStem’s research is funded in part by support from the Alzheimer’s Drug Discovery Foundation, Harrington Discovery Institute, Alzheimer’s Association, Rainwater Charitable Foundation, Muscular Dystrophy Association, Department of Defense, and the National Institute of Neurological Disorders and Stroke.
- The Chief Scientific Officer (CSO) will partner with the CEO to advance AcuraStem’s mission of discovering and developing more effective treatments for neuroscience indications and advancing them quickly to patients leveraging its patient-based approach and iNeuroRx technology platform.
- The CSO is expected to manage and advance AcuraStem’s scientific portfolio by discovering and validating new targets, determining the best treatment modality for new targets, and advancing existing antisense oligonucleotide (ASO) therapeutic programs through development into IND-enabling and early clinical studies.
- Reporting to and partnering with the CEO, the CSO will be a critical decision maker in managing and prioritizing the strategy for neuroscience therapeutics discovery, development, and platform technology expansion.
Active Job
Updated TodaySimilar Job
Relevance
Active